Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Articaine hydrochloride (Hoe-045) 一种牙科局部麻醉剂。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
25 mg | ¥ 340 | 现货 | ||
50 mg | ¥ 480 | 现货 | ||
100 mg | ¥ 785 | 现货 | ||
200 mg | ¥ 1,150 | 现货 | ||
500 mg | ¥ 1,950 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 198 | 现货 |
产品描述 | Articaine hydrochloride (Hoe-045) is a thiophene-containing local anesthetic pharmacologically similar to MEPIVACAINE. |
体内活性 | The time to maximum drug concentrations of articaine occurs about 10 to 15 minutes after submucosal injection of articaine 4% 80 mg. The elimination half-time of articaine is about 20 minutes. Articaine is better able to diffuse through soft tissue and bone than other local anaesthetics, the concentration of articaine in the alveolus of a tooth in the upper jaw after extraction is about 100 times higher than that in systemic circulation. [1] Articaine: VAS (Visual Analogue Scale) scores (from 0 to 10 cm) by patients 4 to < 13 years of age are 0.5 for simple procedures and 1.1 for complex procedures, and average investigator scores are 0.4 and 0.6 for simple and complex procedures, respectively. No serious adverse events related to the articaine occurres, the only adverse event considered related to articaine is accidental lip injury in one patient. [2] Articaine results in success rate of 64.5% in electronic pulp testing in healthy adult volunteers injected with 4% articaine. Articaine infiltration produces significantly more episodes of no response to maximum stimulation in first molars than lidocaine. Mandibular buccal infiltration is more effective with 4% articaine with epinephrine compared to 2% lidocaine with epinephrine. [3] Articaine (4%) results in the success rate of 24% for the inferior alveolar nerve block in randomized, double-blind study. [4] Articaine formulation results in successful pulpal anesthesia ranged from 75 to 92 percent and onset of pulpal anesthesia ranged from 4.2 to 4.7 minutes in healthy volunteer. For articaine, 4 percent (two of 56) of the subjects reported swelling and no subjects reported bruising. Ninety-eight percent (59 of 60) of the subjects had lip numbness with the articaine solution. [5] |
别名 | Ultracaine, 盐酸阿替卡因, 阿替卡因, Articaine HCl, Hoe-045 |
分子量 | 320.84 |
分子式 | C13H21ClN2O3S |
CAS No. | 23964-57-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 60 mg/mL (187.01 mM)
H2O: 59 mg/mL (183.9 mM)
Ethanol: 60 mg/mL (187 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO / H2O / Ethanol | 1 mM | 3.1168 mL | 15.5841 mL | 31.1682 mL | 77.9205 mL |
5 mM | 0.6234 mL | 3.1168 mL | 6.2336 mL | 15.5841 mL | |
10 mM | 0.3117 mL | 1.5584 mL | 3.1168 mL | 7.792 mL | |
20 mM | 0.1558 mL | 0.7792 mL | 1.5584 mL | 3.896 mL | |
50 mM | 0.0623 mL | 0.3117 mL | 0.6234 mL | 1.5584 mL | |
100 mM | 0.0312 mL | 0.1558 mL | 0.3117 mL | 0.7792 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Articaine hydrochloride 23964-57-0 Membrane transporter/Ion channel Sodium Channel dental Articaine Articaine Hydrochloride NOD-like Receptor (NLR) Ultracaine Hoe 045 amide pain relief Hoe045 盐酸阿替卡因 inhibit Na channels kidney injury 阿替卡因 Nuclear factor-κB LPS NF-κB Na+ channels Articaine HCl Nuclear factor-kappaB Hoe-045 Inhibitor inhibitor